US Patent 12,667,564 — assignment history and current owner
US 12,667,564 · Application 17/536,892
Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha, Beta-unsaturated Ketone Compounds
Who owns US Patent 12,667,564?
US12667564 ("Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha, Beta-unsaturated Ketone Compounds") — current assignee: SPECGX LLC. Status: Active, estimated expiration March 2, 2027. 5 recorded USPTO assignments.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,667,564 is SPECGX LLC. Based on the most recent ownership transfer record (recorded 2024-12-16).
- Patent title
- Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha, Beta-unsaturated Ketone Compounds
- Application number
- 17/536,892
- Apparent operating assignee
- SPECGX LLC
- Patent status
- Active, estimated expiration March 2, 2027
- Recorded assignments
- 5
Note: a security interest appears active (WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT) with no recorded release. Security interests reflect financing arrangements, not operating ownership.
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Nov 14, 2023 | Nov 15, 2023 | Security Interest | MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC | ACQUIOM AGENCY SERVICES LLC | 65595/376 |
| Apr 27, 2006 | Dec 16, 2024 | Ownership Transfer | BUEHLER, HENRY J.; DUMMITT, WILLIAM E.; AUBUCHON, DENNIS C.; MANNINO, ANTHONY; GU, HONG | MALLINCKRODT INC. | 69594/429 |
| Dec 13, 2017 | Dec 16, 2024 | Ownership Transfer | MALLINCKRODT LLC | SPECGX LLC | 69594/490 |
| Jul 31, 2025 | Jul 31, 2025 | Security Agreement | SPECGX LLC | WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT | 72313/63 |
| Aug 1, 2025 | Aug 14, 2025 | Release of Security Interest | ACQUIOM AGENCY SERVICES LLC | MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC | 72324/740 |
Scrolls sideways on narrow screens
Chain of title
In 2024, BUEHLER, HENRY J.; DUMMITT, WILLIAM E. (+3 more) assigned the patent to MALLINCKRODT INC.. The most recent ownership transfer, recorded in 2024, lists SPECGX LLC as assignee. In 2025, WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
Ownership settled? Give your AI the file.
Application 17/536,892 · US 12,667,564
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,667,564, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.